Pubblicazioni

Managing Children and Adolescents with Chronic Myeloid Leukemia Treated with High-Dose Imatinib. The Italian Experience.

2016 - HAEMATOLOGICA

Giona, F; Saglio, G; Santopietro, M; Menna, G; Putti, Mc; Micalizzi, C; Iaria, G; Santoro, N; Ladogana, S; Mura, R; Burnelli, R; Consarino, C; Cosmi, C; Moleti, Ml; Varotto, S; Tucci, F; Nanni, M; Diverio, D; Biondi, A; Locatelli, F; FoÃ , R

Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing Î±Î²+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies

2016 - HAEMATOLOGICA

Muccio, L.; Bertaina, A.; Falco, M.; Pende, D.; Meazza, R.; Lopez-Botet, M.; Moretta, L.; Locatelli, F.; Moretta, A.; Della Chiesa, M.

Lack of splice factor and cohesin complex mutations in pediatric myelodysplastic syndrome

2016 - HAEMATOLOGICA

Obenauer, J. C.; Kavelaars, F. G.; Sanders, M. A.; Hoogenboezem, R. M.; De Vries, A. C. H.; Van Strien, P. M. H.; De Haas, V.; Locatelli, F.; Hasle, H.; Valk, P. J. M.; Touw, I. P.; Van Den Heuvel-Eibrink, M. M.

Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients

2016 - HAEMATOLOGICA

Castagnetti, F; Breccia, M; Gugliotta, G; Martino, B; D'Adda, M; Stagno, F; Carella, Am; Avanzini, P; Tiribelli, M; Trabacchi, E; Visani, G; Gobbi, M; Salvucci, M; Levato, L; Binotto, G; Capalbo, Sf; Bochicchio, Mt; Soverini, S; Cavo, M; Martinelli, G; Alimena, G; Pane, F; Saglio, G; Rosti, G; Baccarani, M

CHRONIC MYELOID LEUKEMIA WITH EXTREME THROMBOCYTOCIS AT THE DIAGNOSIS: A NEW SUBSET

2016 - HAEMATOLOGICA

Sora, F; Alessandra, I; Latagliata, R; Castagnetti, F; Fava, C; Annunziata, M; Gozzini, A; Montefusco, E; Avanzini, P; Pregno, P; Cerrano, M; Celesti, F; Galimberti, S; Bocchia, M; Breccia, M; Cattaneo, D; Rosti, G; Sica, S

DEFERASIROX IN THE TREATMENT OF IRON OVERLOAD DURING MYELOPROLIFERATIVE NEOPLASMS (MPN)

2016 - HAEMATOLOGICA

Porrini, R; De Muro, M; Trawinska, M; Di Veroli, A; Leonetti, Sc; Petriccione, L; Spadea, A; D'Addosio, A; Rago, A; Montanaro, M; Andriani, A; Niscola, P; Montefusco, E; Breccia, M; Alimena, G; Latagliata, R

AZACITIDINE IN THE TREATMENT OF PH- MYELOPROLIFERATIVE NEOPLASMS IN BLASTIC PHASE: THE EXPERIENCE OF GRUPPO LAZIALE FOR THE STUDY OF PH- SMPC

2016 - HAEMATOLOGICA

Di Veroli, A; Anaclerico, B; Villiva, N; Niscola, P; Montanaro, M; Cimino, G; Voso, Mt; Trawinska, M; Andriani, A; Fianchi, L; Breccia, M; Latagliata, R

IS A 1ST LINE ERYTHROPOIETIN APPROACH IN MYELODYSPLASTIC PATIENTS WITH DEL 5Q-USEFUL?

2016 - HAEMATOLOGICA

Volpicelli, P; Mancini, M; Ferretti, A; Carmosino, I; De Luca, Ml; Vozella, F; Trasarti, S; Sangiorgi, E; Lisi, C; Breccia, M; Latagliata, R; Alimena, G

A PROSPECTIVE EVALUATION OF THE IMPACT OF TRANSFUSION DEPENDENCY ON QUALITY OF LIFE AND SYMPTOM BURDEN IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

2016 - HAEMATOLOGICA

Efficace, F; Gaidano, G; Niscola, P; Breccia, M; Caocci, G; Angelucci, E; Santini, V; Buccisano, F; Bergamaschi, M; Luppi, M; Borin, L; Stauder, R; Palumbo, Ga; Cottone, F; Karakantza, M; Califano, C; Crugnola, M; Invernizzi, R; Sarlo, C; Fozza, C; Zhang, H; Platzbecker, U; Amadori, S; Vignetti, M; Mandelli, F

Efficacy and safety of second-line ponatinib after failure of a single previous tyrosine kinase inhibitor for chronic myeloid leukemia patients in chronic phase

2016 - HAEMATOLOGICA

Breccia, M; Abruzzese, E; Iurlo, A; Gozzini, A; Isidori, A; Gangemi, D; Pregno, P; Alimena, G

PREDICTORS FOR RESPONSE TO RUXOLITINIB IN REAL-LIFE: AN OBSERVATIONAL INDEPENDENT STUDY ON 266 PATIENTS WITH MYELOFIBROSIS

2016 - HAEMATOLOGICA

Polverelli, N; Benevolo, G; Palumbo, Ga; Bonifacio, M; Tiribelli, M; Martino, B; Tieghi, A; Breccia, M; Ibatici, A; Crugnola, M; Bosi, C; Catani, L; Scaffidi, L; de Marchi, F; Lazzaro, A; Aversa, F; Di Raimondo, F; Vallisa, D; Vitolo, U; Merli, F; Fanin, R; Alimena, G; Martinelli, G; Cavo, M; Vianelli, N; Palandri, F

HOW PATIENTS PERCEIVE A SWITCH FROM IMATINIB TO NILOTINIB: RESULTS OF A PATIENT-CENTERED ANALYSIS

2016 - HAEMATOLOGICA

Breccia, M; Sora, F; Annunziata, M; Iovine, M; Caocci, G; Luciano, L; Franceschini, L; Falzetti, F; Morabito, F; Rossi, Ar; Celesti, F; Scortechini, Ar; Iurlo, A; Bergamaschi, M; Stagno, F; Avanzini, P; Bonifacio, M; Binotto, G; Fabbiano, F; Gozzini, A; Pregno, P; Martino, B; Salvucci, M; Cecchini, I; De Santis, E; Pennella, A; Rosti, G; Abruzzese, E

HOME CARE ADMINISTRATION OF SUBCUTANEOUS AZACITIDINE (AZA) AND DOMICILIARY MANAGEMENT OF FRAIL PATIENTS AFFECTED BY ACUTE MYELOID LEUKEMIA/MYELODYSPLASTIC SYNDROME: A FEASIBILITY STUDY

2016 - HAEMATOLOGICA

Cartoni, C; Carmosino, I; Brunetti, Ga; Latagliata, R; Minotti, C; Palumbo, G; Morano, Sg; Grammatico, S; Annechini, G; Breccia, M; Mandelli, F; Foa, R

EFFICACY AND SAFETY OF FIRST-LINE TREATMENT WITH NILOTINIB IN ELDERLY CHRONIC MYELOID LEUKEMIA PATIENTS

2016 - HAEMATOLOGICA

Gugliotta, G; Castagnetti, F; Breccia, M; D'Adda, M; Stagno, F; Levato, L; Carella, Am; Martino, B; Tiribelli, M; Rege-Cambrin, G; Gozzini, A; Salvucci, M; Cedrone, M; Trabacchi, E; Usala, E; Scortechini, Ar; Luciano, L; Soverini, S; Alimena, G; Cavo, M; Martinelli, G; Pane, F; Saglio, G; Baccarani, M; Rosti, G

SAFETY AND EFFICACY OF RUXOLITINIB IN CLINICAL PRACTICE FOR PRIMARY AND SECONDARY MYELOFIBROSIS

2016 - HAEMATOLOGICA

Breccia, M; Andriani, A; Montanaro, M; Abruzzese, E; Buccisano, F; Cedrone, M; Centra, A; Villiva, N; Celesti, F; Trawinska, Mm; Di Veroli, A; Anaclerico, B; Colafigli, G; Spadea, A; Petriccione, L; Cimino, G; Latagliata, R; Alimena, G

THE EUTOS LONG-TERM SURVIVAL SCORE IS PREDICTIVE FOR RESPONSE AND OUTCOME IN CML PATIENTS TREATED FRONTLINE WITH NILOTINIB-BASED REGIMENS

2016 - HAEMATOLOGICA

Castagnetti, F; Gugliotta, G; Breccia, M; Stagno, F; D'Adda, M; Levato, L; Carella, Am; Martino, B; Tiribelli, M; Fava, C; Binotto, G; Avanzini, P; Bocchia, M; Bergamaschi, M; Russo-Rossi, A; Cavazzini, F; Abruzzese, E; Soverini, S; Alimena, G; Cavo, M; Martinelli, G; Pane, F; Saglio, G; Baccarani, M; Rosti, G

MEANING OF MOLECULAR RESPONSES FLUCTUATION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH LONG-TERM IMATINIB

2016 - HAEMATOLOGICA

Breccia, M; Molica, M; Colafigli, G; Quattrocchi, L; Saracino, R; Latagliata, R; Mancini, M; Diverio, D; Alimena, G

2013 EUROPEAN LEUKEMIANET RESPONSE CRITERIA VALIDATION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH 3 AVAILABLE TKIS OUTSIDE CLINICAL TRIALS

2016 - HAEMATOLOGICA

Breccia, M; Pregno, P; Annunziata, M; Orlandi, E; Gozzini, A; Iurlo, A; Bocchia, M; Franceschini, L; Montefusco, E; Crugnola, M; La Nasa, G; Scortechini, Ar; Sgherza, N; Sica, S; Alimena, G; Saglio, G; Specchia, G

Dexamethasone targeted directly to macrophages induces macrophage niches that promote erythroid expansion.

2015 - HAEMATOLOGICA

Falchi, M; Varricchio, L; Martelli, F; Masiello, F; Federici, Giulia; Zingariello, M; Girelli, Gabriella; Whitsett, C; Petricoin, Ef; Moestrup, Sk; Zeuner, A; Migliaccio, A. R.

Multifunctional human CD56low CD16low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients.

2015 - HAEMATOLOGICA

Stabile, MARIA HELENA; Nisti, Paolo; Morrone, Stefania; Pagliara, D; Bertaina, A; Locatelli, F; Santoni, Angela; Gismondi, Angela

Response to comment on multifunctional human CD56<sup>low</sup>CD16<sup>low</sup> NK cells are the prominent subset in bone marrow of both pediatric healthy donors and leukemic patients

2015 - HAEMATOLOGICA

Stabile, MARIA HELENA; Nisti, Paolo; Pagliara, Daria; Locatelli, Franco; Santoni, Angela; Gismondi, Angela

The pan-class I PI3 kinase inhibitor, NVP-BKM120, demonstrates anti-leukemic activity in acute myeloid leukemia

2015 - HAEMATOLOGICA

Allegretti, Matteo; Ricciardi, Maria Rosaria; Licchetta, Roberto; Mirabilii, Simone; Orecchioni, Stefania; Reggiani, Francesca; Talarico, Giovanna; Foa, Roberto; Bertolini, Francesco; Amadori, Sergio; Tafuri, Agostino

TPO-RECEPTOR AGONISTS AS TREATMENT PREPARING ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA TO SPLENECTOMY. RESULTS OF A RETROSPECTIVE, OBSERVATIONAL STUDY (GIMEMA ITP0614)

2015 - HAEMATOLOGICA

Zaja, F; Barcellini, W; Cantoni, S; Carpenedo, M; Caparrotti, G; Carrai, V; Di Renzo, N; Santoro, Cristina; Di Nicola, M; Veneri, D; Simonetti, F; Liberati, Am; Ferla, V; Paoloni, F; Crea, E; Tuniz, E; Fanin, R.

THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS AFFECTED BY PRIMARY IMMUNE THROMBOCYTOPENIA: ANALYSIS OF POSSIBLE PREDICTIVE FACTORS FOR SUSTAINED AND DURABLE RESPONSE FROM A RETROSPECTIVE CASE SERIES

2015 - HAEMATOLOGICA

Santoro, Cristina; De Angelis, F; Baldacci, Erminia; Abbruzzese, R; Barone, Francesco; Bochicchio, Ar; Chisini, Marta; Ferrara, G; Mattone, Pf; Volpicelli, P; Foa, Roberto; Mazzucconi, Maria Gabriella

ROLE OF TREATMENT ON THE DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ESSENTIAL THROMBOCYTEMIA

2015 - HAEMATOLOGICA

Santoro, Cristina; Sperduti, I; Di Giandomenico, J; De Muro, M; Villiva, N; Di Veroli, A; Montanaro, M; Latagliata, R; Anaclerico, B; Avvisati, G; Breccia, M; Cedrone, M; Cimino, Giuseppe; Felici, S; Ferrara, G; Crescenzi, Sl; Majolino, I; Montefusco, E; Montanaro, G; Porrini, R; Rago, A; Spadea, A; Spirito, F; Alimena, G; Andriani, A; Foa, Roberto; Mazzucconi, Maria Gabriella